Evaluating the effects of lenalidomide induction therapy on peripheral stem cells collection in patients undergoing autologous stem cell transplant for multiple myeloma

INTRODUCTION: Lenalidomide (LEN) is a relatively new and very effective therapy for multiple myeloma (MM). Prior LEN therapy is associated with an increased risk of peripheral blood stem cell collection (PBSC) failure, particularly with filgrastim (G-CSF) alone. We performed a retrospective chart re...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Bhutani, Divaya, Zonder, Jeffrey, Valent, Jason, Tageja, Nishant, Ayash, Lois, Deol, Abhinav, Al-Kadhimi, Zaid, Abrams, Judith, Lum, Lawrence, Ratanatharathorn, Voravit, Uberti, Joseph, Abidi, Muneer H.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2013
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3837683/
https://ncbi.nlm.nih.gov/pubmed/23591714
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-013-1808-5
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia